Literature DB >> 18267345

Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters.

Niki Panakis1, Helen A McNair, Judith A Christian, Ruheena Mendes, J Richard N Symonds-Tayler, Clifford Knowles, Philip M Evans, James Bedford, Michael Brada.   

Abstract

BACKGROUND: The effectiveness of ABC has been traditionally measured as the reduction in internal margin (IM) within the planning target volume (PTV). Not to overestimate the benefit of ABC, the effect of patient movement during treatment also needs to be taken into account. We determined the IM and set-up error with ABC and the effect on physical lung parameters compared to standard margins used with free breathing. We also assessed interfraction oesophageal movement to determine a planning organ at risk volume (PRV).
MATERIALS AND METHODS: Two sequential studies were performed using ABC in NSCLC patients suitable for radical radiotherapy (RT). Twelve out of 14 patients in Study 1 had tumours visible fluoroscopically and had intrafraction tumour movement assessed with and without ABC. Sixteen patients were recruited to Study 2 and had interfraction tumour movement measured using ABC in a moderate deep inspiration breath-hold, of these 7 patients also had interfraction oesophageal movement recorded. Interfraction movement was assessed by CT scan prior to and in the middle and final week of RT. Displacement of the tumour centre of mass and oesophageal borders relative to the first scan provided a measure of movement. Set-up error was measured in 9 patients treated with an in-house lung board adapted for the ABC device. Combining movement and set-up errors determined PTV and PRV margins with ABC. The effect of ABC on mean lung dose (MLD), lung V20 and V13 was calculated.
RESULTS: ABC in a moderate deep inspiration breath-hold was tolerated in 25 out of 30 patients (83%) in Study 1 and 2. The random contribution of periodic tumour motion was reduced by 90% in the y direction with ABC compared to free-breathing. The magnitude of motion reduction was less in the x and z direction. Combining the systematic and random set-up error in quadrature with the systematic and random intrafraction and interfraction tumour variations with ABC results in a PTV margin of 8.3mm in the x direction, 12.0mm in the y direction and 9.8mm in the z direction. There was a relative mean reduction in MLD, lung V20 and V13 of 25%, 21% and 18% with the ABC PTV compared to a free-breathing PTV. Oesophageal movement combined with set-up error resulted in an isotropic PRV of 4.7 mm.
CONCLUSIONS: The reduction in PTV size with ABC resulted in an 18-25% relative reduction in physical lung parameters. PTV margin reduction has the potential to spare normal lung and allow dose-escalation if coupled with image-guided RT. The oesophageal PRV needs to be considered when irradiating central disease and is of increasing importance with altered RT fractionation and concomitant chemoradiation schedules. Further reductions in PTV and PRV may be possible if patient set-up error was minimised, confirming that attention to patient immobilisation is as important as attempts to control tumour motion.

Entities:  

Mesh:

Year:  2008        PMID: 18267345     DOI: 10.1016/j.radonc.2007.12.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  22 in total

1.  Localization accuracy from automatic and semi-automatic rigid registration of locally-advanced lung cancer targets during image-guided radiation therapy.

Authors:  Scott P Robertson; Elisabeth Weiss; Geoffrey D Hugo
Journal:  Med Phys       Date:  2012-01       Impact factor: 4.071

2.  [Image-guided radiation therapy].

Authors:  J Boda-Heggemann; M Guckenberger; U Ganswindt; C Belka; H Wertz; M Blessing; F Wenz; M Fuss; F Lohr
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

3.  Quality and accuracy of cone beam computed tomography gated by active breathing control.

Authors:  Bria P Thompson; Geoffrey D Hugo
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

Review 4.  Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Authors:  Anna O Simeonova; Katharina Fleckenstein; Hansjörg Wertz; Anian Frauenfeld; Judit Boda-Heggemann; Frank Lohr; Frederik Wenz
Journal:  Transl Lung Cancer Res       Date:  2012-03

5.  Automatically gated image-guided breath-hold IMRT is a fast, precise, and dosimetrically robust treatment for lung cancer patients.

Authors:  Anna Simeonova-Chergou; Anika Jahnke; Kerstin Siebenlist; Florian Stieler; Sabine Mai; Judit Boda-Heggemann; Frederik Wenz; Frank Lohr; Lennart Jahnke
Journal:  Strahlenther Onkol       Date:  2016-01-15       Impact factor: 3.621

6.  Tumor, lymph node, and lymph node-to-tumor displacements over a radiotherapy series: analysis of interfraction and intrafraction variations using active breathing control (ABC) in lung cancer.

Authors:  Elisabeth Weiss; Scott P Robertson; Nitai Mukhopadhyay; Geoffrey D Hugo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-22       Impact factor: 7.038

7.  Application of a deformable registration technique to investigate breath-hold reproducibility.

Authors:  Nobuyoshi Fukumitsu; Yasutaka Hayashi
Journal:  Jpn J Radiol       Date:  2014-11-08       Impact factor: 2.374

8.  Anatomic and pathologic variability during radiotherapy for a hybrid active breath-hold gating technique.

Authors:  Carri K Glide-Hurst; Ellen Gopan; Geoffrey D Hugo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-01       Impact factor: 7.038

9.  Hypofractionated radiotherapy for lung tumors with online cone beam CT guidance and active breathing control.

Authors:  Yali Shen; Hong Zhang; Jin Wang; Renming Zhong; Xiaoqing Jiang; Qinfeng Xu; Xin Wang; Sen Bai; Feng Xu
Journal:  Radiat Oncol       Date:  2010-02-27       Impact factor: 3.481

10.  Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University.

Authors:  Vieri Scotti; Livia Marrazzo; Calogero Saieva; Benedetta Agresti; Icro Meattini; Isacco Desideri; Sara Cecchini; Silvia Bertocci; Ciro Franzese; Carla De Luca Cardillo; Giacomo Zei; Mauro Loi; Daniela Greto; Monica Mangoni; Pieroluigi Bonomo; Lorenzo Livi; Gian Paolo Biti
Journal:  Radiol Med       Date:  2013-11-15       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.